心不全POCおよびLOCデバイス市場：検査タイプ、技術、エンドユーザー別-2023-2030年の世界予測

心不全POCおよびLOCデバイスの世界市場は、2023年にCAGR 19.59%で8,849万米ドルが予測され、2030年には3億1,093万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の心不全POCおよびLOCデバイス市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.心不全POCおよびLOCデバイスの世界市場規模および予測は？

2.予測期間中、世界の心不全POCおよびLOCデバイス市場を形成するCOVID-19の阻害要因と影響は？

3.心不全POCおよびLOCデバイスの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.心不全POCおよびLOCデバイスの世界市場における競争戦略は？

5.心不全POCおよびLOCデバイスの世界市場における技術動向と規制の枠組みは？

6.心不全POCおよびLOCデバイスの世界市場における主要ベンダーの市場シェアは？

7.心不全POCおよびLOCデバイスの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケア費を削減するために病気の早期診断の必要性の高まり
    • センサーやその他のアクセサリを備えた使い捨ての低コスト LOCデバイスの開発が拡大
    • 政府によるヘルスケア支出の増加を軽減するためのPOCおよびLOCデバイスの採用の増加
  • 抑制要因
    • 複数のテストを実行するカートリッジを備えたPOCデバイスに対する標準償還の欠如
  • 機会
    • 技術の進歩により、新規バイオマーカーの同定に向けた調査活動が増加
    • 治療モニタリングのためにLOCアッセイデータを分析するための予測モデリング技術の新たな開発
  • 課題
    • 人々のアクセシビリティと意識の低下
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 心不全POCおよびLOCデバイス市場テストタイプ別

• ゲノム検査
• メタボローム検査
• プロテオミクス検査

第7章 心不全POCおよびLOCデバイス市場：技術別

• アレイベースのシステム
• マイクロ流体工学

第8章 心不全POCおよびLOCデバイス市場：エンドユーザー別

• 生活支援ヘルスケア施設
• クリニック
• 家
• 病院
• ラボ

第9章 南北アメリカの心不全POCおよびLOCデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心不全POCおよびLOCデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心不全POCおよびLOCデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. HEART FAILURE POC & LOC DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2022 VS 2030
• FIGURE 3. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
• FIGURE 5. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 6. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. HEART FAILURE POC & LOC DEVICES MARKET DYNAMICS
• FIGURE 9. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HEART FAILURE POC & LOC DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 5. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 9. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ARRAY-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 12. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 145. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 146. HEART FAILURE POC & LOC DEVICES MARKET LICENSE & PRICING

The Global Heart Failure POC & LOC Devices Market is forecasted to grow significantly, with a projected USD 88.49 million in 2023 at a CAGR of 19.59% and expected to reach a staggering USD 310.93 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Heart Failure POC & LOC Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Heart Failure POC & LOC Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Test Type, market is studied across Genomic Testing, Metabolomic Testing, and Proteomic Testing. The Proteomic Testing is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Array-based Systems and Microfluidics. The Array-based Systems is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratory. The Assisted Living Healthcare Facilities is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Heart Failure POC & LOC Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Heart Failure POC & LOC Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Heart Failure POC & LOC Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Heart Failure POC & LOC Devices Market?

4. What is the competitive strategic window for opportunities in the Global Heart Failure POC & LOC Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Heart Failure POC & LOC Devices Market?

6. What is the market share of the leading vendors in the Global Heart Failure POC & LOC Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Heart Failure POC & LOC Devices Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Heart Failure POC & LOC Devices Market, by Test Type, 2022 vs 2030
• 4.3. Heart Failure POC & LOC Devices Market, by Technology, 2022 vs 2030
• 4.4. Heart Failure POC & LOC Devices Market, by End-user, 2022 vs 2030
• 4.5. Heart Failure POC & LOC Devices Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for early diagnosis of diseases to reduce healthcare costs
    • 5.1.1.2. Growing development of disposable and low-cost LOC devices with sensors and other accessories
    • 5.1.1.3. Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in technology to increase research activities for the identification of novel biomarkers
    • 5.1.3.2. Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Reduced accessibility and awareness among the population
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Heart Failure POC & LOC Devices Market, by Test Type

• 6.1. Introduction
• 6.2. Genomic Testing
• 6.3. Metabolomic Testing
• 6.4. Proteomic Testing

7. Heart Failure POC & LOC Devices Market, by Technology

• 7.1. Introduction
• 7.2. Array-based Systems
• 7.3. Microfluidics

8. Heart Failure POC & LOC Devices Market, by End-user

• 8.1. Introduction
• 8.2. Assisted Living Healthcare Facilities
• 8.3. Clinics
• 8.4. Home
• 8.5. Hospitals
• 8.6. Laboratory

9. Americas Heart Failure POC & LOC Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Heart Failure POC & LOC Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Heart Failure POC & LOC Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing